An Update on Current Usage of SGLT2-Inhibitors in Diabetic Kidney Disease: Special Focus on Dapagliflozin
Deodatta S. Chafekar, Pinaki Mukherjee, K. N. Arun, Manish Malik, Biswajit Aich & Sameer K. Muchhala · International Journal of Advances in Nephrology Research · 2023
Diabetic Kidney Disease (DKD) is one of the most serious long-term outcomes in patients with T2DM. Prevalence of DKD is predicted to increase as the prevalence of diabetes is growing rapidly thereby leading to substantial morbidity and mortality. Established therapies still focus...
Open access
Research Article